IMRX(IMRX)
IMRX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $21M | $14M | $41M | $81M | $182M |
| Low | $21M | $14M | $41M | $81M | $182M |
| High | $21M | $14M | $41M | $81M | $182M |
| EBITDA Avg | $4M | $3M | $8M | $16M | $36M |
| Low | $4M | $3M | $8M | $16M | $36M |
| High | $4M | $3M | $8M | $16M | $36M |
| EBIT Avg | $4M | $3M | $8M | $16M | $36M |
| Low | $4M | $3M | $8M | $16M | $36M |
| High | $4M | $3M | $8M | $16M | $36M |
| Net Income Avg | $-47M | $-59M | $-96M | $-40M | $-7M |
| Low | $-53M | $-68M | $-98M | $-40M | $-7M |
| High | $-42M | $-49M | $14M | $-40M | $-7M |
| EPS Avg | $-1.11 | $-1.33 | $-1.30 | $-0.91 | $-0.16 |
| Low | $-1.20 | $-1.55 | $-2.23 | $-0.91 | $-0.16 |
| High | $-0.94 | $-1.12 | $0.32 | $-0.91 | $-0.16 |
| Analysts (Rev / EPS) | 6 / 5 | 6 / 4 | 5 / 5 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EBITDA Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — |
| Low | — | — | — | — | — | — |
| High | — | — | — | — | — | — |
| Net Income Avg | $-13M | $-15M | $-14M | $-16M | $-17M | $-18M |
| Low | $-15M | $-15M | $-14M | $-16M | $-17M | $-18M |
| High | $-12M | $-15M | $-14M | $-16M | $-17M | $-18M |
| EPS Avg | $-0.31 | $-0.33 | $-0.33 | $-0.36 | $-0.39 | $-0.41 |
| Low | $-0.35 | $-0.33 | $-0.33 | $-0.36 | $-0.39 | $-0.41 |
| High | $-0.26 | $-0.33 | $-0.33 | $-0.36 | $-0.39 | $-0.41 |
| Analysts (Rev / EPS) | — / 4 | — / 2 | — / 2 | — / 1 | — / 1 | — / 2 |